LEP and metabolic syndrome: Considering that leptin exerts multiple functions, regulating the metabolic rate and energy expenditure [154,155,156], and that leptin resistance is often observed in obese patients [13,16,17], we propose that the pharmacological blockade of the TRPM7 channels in the CB could be a potential and more feasible therapy for metabolic syndrome.